MedPath
HSA Approval

METAGARD TABLET 20 mg

SIN11607P

METAGARD TABLET 20 mg

METAGARD TABLET 20 mg

August 3, 2001

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C01EB15

trimetazidine

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

IPCA LABORATORIES LTD

Active Ingredients

TRIMETAZIDINE 2HCl

20 mg

Trimetazidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

METAGARD TABLET 20 mg - HSA Approval | MedPath